Advertisement
UK markets close in 1 hour 8 minutes
  • FTSE 100

    8,435.48
    +54.13 (+0.65%)
     
  • FTSE 250

    20,652.58
    +121.28 (+0.59%)
     
  • AIM

    789.69
    +5.99 (+0.76%)
     
  • GBP/EUR

    1.1620
    +0.0009 (+0.08%)
     
  • GBP/USD

    1.2514
    -0.0010 (-0.08%)
     
  • Bitcoin GBP

    49,788.05
    +900.45 (+1.84%)
     
  • CMC Crypto 200

    1,302.78
    -55.23 (-4.07%)
     
  • S&P 500

    5,225.83
    +11.75 (+0.23%)
     
  • DOW

    39,541.90
    +154.14 (+0.39%)
     
  • CRUDE OIL

    79.53
    +0.27 (+0.34%)
     
  • GOLD FUTURES

    2,373.40
    +33.10 (+1.41%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,761.28
    +74.68 (+0.40%)
     
  • CAC 40

    8,228.10
    +40.45 (+0.49%)
     

Why Moderna Stock Jumped 10.7% Today

Why Moderna Stock Jumped 10.7% Today

Shares of Moderna (NASDAQ: MRNA) rose more than 10% on Friday after the biotechnology company announced the commencement of its Phase 2 study for its novel coronavirus vaccine. Moderna said the first participants in each age group of its Phase 2 study have received doses of its experimental COVID-19 vaccine, mRNA-1273. Moderna is seeking to enroll 600 healthy participants, including 300 people aged 18-55 and 300 people older than 55.